Quarterly report pursuant to Section 13 or 15(d)

EQUITY - Summary of Equity Instruments Other than Options (Details)

v3.23.2
EQUITY - Summary of Equity Instruments Other than Options (Details) - $ / shares
 1 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
May 31, 2023
Nonvested, Number of Shares      
Granted (in shares)   300,000  
Warrants      
Nonvested, Number of Shares      
Issued and outstanding at beginning of period (in shares)   86,048,837  
Cancelled/forfeited/expired (in shares)   (100,000)  
Issued and outstanding at end of period (in shares) 86,248,837 86,248,837  
Weighted - Average Exercise Price      
Issued and outstanding at beginning of period (in dollars per share)   $ 1.40  
Granted, weighted-average per share grant date fair value (in dollars per share)   0.48  
Cancelled/forfeited/expired (in dollars per share)   1.47  
Issued and outstanding at end of period (in dollars per share) $ 1.16 $ 1.16  
Exercisable      
Nonvested, Number of Shares, Exercisable (in shares) 83,848,837 83,848,837  
Weighted - Average Exercise Price, Exercisable (in dollars per share) $ 1.14 $ 1.14  
Warrants | Non-Derivative (Equity) Warrants      
Nonvested, Number of Shares      
Issued and outstanding at beginning of period (in shares)   30,673,635  
Granted (in shares)   300,000  
Cancelled/forfeited/expired (in shares)   (100,000)  
Reclassification (in shares) 17,512,280 17,512,280  
Issued and outstanding at end of period (in shares) 48,385,915 48,385,915  
Exercisable      
Nonvested, Number of Shares, Exercisable (in shares) 45,985,915 45,985,915  
Repriced in period (in dollars per share) $ 1.00 $ 1.00 $ 2.086
Warrants | Derivative Liability Warrants      
Nonvested, Number of Shares      
Issued and outstanding at beginning of period (in shares)   55,375,202  
Granted (in shares)   0  
Cancelled/forfeited/expired (in shares)   0  
Reclassification (in shares)   (17,512,280)  
Issued and outstanding at end of period (in shares) 37,862,922 37,862,922  
Exercisable      
Nonvested, Number of Shares, Exercisable (in shares) 37,862,922 37,862,922  
Repriced in period (in shares) 5,890,000    
Repriced in period (in dollars per share) $ 1.00 $ 1.00 $ 1.25
Restricted stock      
Nonvested, Number of Shares      
Issued and outstanding at beginning of period (in shares)   1,156,319  
Cancelled/forfeited/expired (in shares)   (53,001)  
Vested and Released (in shares)   (1,097,823)  
Issued and outstanding at end of period (in shares) 5,495 5,495